Quantitative proteomic profiling of cerebrospinal fluid to identify candidate biomarkers for Alzheimer's disease

G Sathe, CH Na, S Renuse… - PROTEOMICS …, 2019 - Wiley Online Library
Purpose The aim of this study is to identify the potential cerebrospinal fluid (CSF) biomarkers
for Alzheimer's disease and to evaluate these markers on independent CSF samples using …
被引用次数：114 相关文章

Quantitative Proteomic Profiling of Cerebrospinal Fluid to Identify Candidate Biomarkers for Alzheimer's Disease

G Sathe, CH Na, S Renuse, AK Madugundu… - PROTEOMICS–Clinical …, 2019 - par.nsf.gov
PurposeThe aim of this study is to identify the potential cerebrospinal fluid (CSF) biomarkers
for Alzheimer's disease and to evaluate these markers on independent CSF samples using …

Quantitative Proteomic Profiling of Cerebrospinal Fluid to Identify Candidate Biomarkers for Alzheimer's Disease

G Sathe, CH Na, S Renuse… - Proteomics …, 2019 - discovery.dundee.ac.uk
Purpose: The aim of this study is to identify the potential cerebrospinal fluid (CSF)
biomarkers for Alzheimer's disease and to evaluate these markers on independent CSF …

Quantitative Proteomic Profiling of Cerebrospinal Fluid to Identify Candidate Biomarkers for Alzheimer's Disease

G Sathe, CH Na, S Renuse… - Proteomics …, 2019 - pubmed.ncbi.nlm.nih.gov
Purpose The aim of this study is to identify the potential cerebrospinal fluid (CSF) biomarkers
for Alzheimer's disease and to evaluate these markers on independent CSF samples using …

Quantitative Proteomic Profiling of Cerebrospinal Fluid to Identify Candidate Biomarkers for Alzheimer's Disease.

G Sathe, CH Na, S Renuse, AK Madugundu… - Proteomics. Clinical …, 2019 - europepmc.org
Quantitative Proteomic Profiling of Cerebrospinal Fluid to Identify Candidate Biomarkers for
Alzheimer's Disease. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …

Quantitative Proteomic Profiling of Cerebrospinal Fluid to Identify Candidate Biomarkers for Alzheimer's Disease

G Sathe, CH Na, S Renuse… - Proteomics-Clinical …, 2019 - pure.johnshopkins.edu
Purpose: The aim of this study is to identify the potential cerebrospinal fluid (CSF)
biomarkers for Alzheimer's disease and to evaluate these markers on independent CSF …
[HTML] nih.gov

[HTML][HTML] Quantitative proteomic profiling of cerebrospinal fluid to identify candidate biomarkers for Alzheimer's disease

G Sathe, CH Na, S Renuse… - Proteomics. Clinical …, 2018 - ncbi.nlm.nih.gov
Purpose Development of novel biomarkers for AD is important for early diagnosis,
monitoring disease progression and therapeutic response. The aim of this study was to …

Quantitative Proteomic Profiling of Cerebrospinal Fluid to Identify Candidate Biomarkers for Alzheimer's Disease

G Sathe, CH Na, S Renuse… - Proteomics …, 2019 - mayoclinic.elsevierpure.com
Purpose: The aim of this study is to identify the potential cerebrospinal fluid (CSF)
biomarkers for Alzheimer's disease and to evaluate these markers on independent CSF …

Quantitative Proteomic Profiling of Cerebrospinal Fluid to Identify Candidate Biomarkers for Alzheimer's Disease.

G Sathe, CH Na, S Renuse, AK Madugundu… - Proteomics. Clinical …, 2019 - europepmc.org
Quantitative Proteomic Profiling of Cerebrospinal Fluid to Identify Candidate Biomarkers for
Alzheimer's Disease. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …